WallStreetZenWallStreetZen

NASDAQ: DAWN
Day One Biopharmaceuticals Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

DAWN earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$188.9M
Current Profit Margin
0%

DAWN Return on Equity

Current Company
-51.7%
Current Industry
-63.5%
Current Market
188%
DAWN's Return on Equity (-51.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when DAWN announces earnings.

DAWN Return on Assets

Current Company
-48.3%
Current Industry
2.9%
DAWN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

DAWN Return on Capital Employed

Current Company
-54.52%
Current Industry
19.5%
DAWN has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

DAWN vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
DAWN$0.00-$188.53M-$188.92MN/AN/A
KNSA$301.77M-$16.36M$8.65M+106.55%-95.74%
VRNA$0.00-$51.16M-$54.37M-100.00%N/A
LGNDN/AN/AN/AN/AN/A
SLNO$0.00-$36.71M-$38.99MN/AN/A
View Top Biotech Stocks

DAWN earnings dates

Next earnings date
May 9, 2024

Day One Biopharmaceuticals Earnings & Revenue FAQ

What were DAWN's earnings last quarter?

On Invalid Date, Day One Biopharmaceuticals (NASDAQ: DAWN) reported Q4 2023 earnings per share (EPS) of -$0.64, up 14.29% year over year. Total Day One Biopharmaceuticals earnings for the quarter were -$54.51 million. In the same quarter last year, Day One Biopharmaceuticals's earnings per share (EPS) was -$0.56.

If you're new to stock investing, here's how to buy Day One Biopharmaceuticals stock.

What was DAWN's earnings growth in the past year?

As of Q2 2024, Day One Biopharmaceuticals's earnings has grown year over year. Day One Biopharmaceuticals's earnings in the past year totalled -$188.92 million.

What is DAWN's earnings date?

Day One Biopharmaceuticals's earnings date is Invalid Date. Add DAWN to your watchlist to be reminded of DAWN's next earnings announcement.

What was DAWN's revenue last quarter?

On Invalid Date, Day One Biopharmaceuticals (NASDAQ: DAWN) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Day One Biopharmaceuticals's revenue was $0.00.

What was DAWN's revenue growth in the past year?

As of Q2 2024, Day One Biopharmaceuticals's revenue has grown null year over year. Day One Biopharmaceuticals's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.